Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-12

Clinical Trial Update: Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing fexofenadine hydrochloride to placebo in patients with ST-elevation myocardial infarction to assess efficacy and safety; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine hydrochloride (fexofenadine hydrochloride)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | Phase 2 | Status: NOT_YET_RECRUITING